Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.

Brooks R, Woods CW, Benjamin DK Jr, Rosenstein NE.

Clin Infect Dis. 2006 Jul 1;43(1):49-54. Epub 2006 May 24.

PMID:
16758417
2.

Assessing the risk of laboratory-acquired meningococcal disease.

Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins BA, Rosenstein NE.

J Clin Microbiol. 2005 Sep;43(9):4811-4. Review.

3.

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team.

Pediatrics. 2005 May;115(5):1220-32.

PMID:
15867028
4.

An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.

Martin SW, Tierney BC, Aranas A, Rosenstein NE, Franzke LH, Apicella L, Marano N, McNeil MM.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):393-401.

PMID:
15717323
5.

Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.

Dull PM, Abdelwahab J, Sacchi CT, Becker M, Noble CA, Barnett GA, Kaiser RM, Mayer LW, Whitney AM, Schmink S, Ajello GW, Dolan-Livengood J, Stephens DS, Cetron MS, Popovic T, Rosenstein NE.

J Infect Dis. 2005 Jan 1;191(1):33-9. Epub 2004 Nov 29.

PMID:
15593000
6.

Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace.

Meehan PJ, Rosenstein NE, Gillen M, Meyer RF, Kiefer MJ, Deitchman S, Besser RE, Ehrenberg RL, Edwards KM, Martinez KF.

MMWR Recomm Rep. 2004 Jun 4;53(RR-7):1-12.

8.

SARS surveillance during emergency public health response, United States, March-July 2003.

Schrag SJ, Brooks JT, Van Beneden C, Parashar UD, Griffin PM, Anderson LJ, Bellini WJ, Benson RF, Erdman DD, Klimov A, Ksiazek TG, Peret TC, Talkington DF, Thacker WL, Tondella ML, Sampson JS, Hightower AW, Nordenberg DF, Plikaytis BD, Khan AS, Rosenstein NE, Treadwell TA, Whitney CG, Fiore AE, Durant TM, Perz JF, Wasley A, Feikin D, Herndon JL, Bower WA, Klibourn BW, Levy DA, Coronado VG, Buffington J, Dykewicz CA, Khabbaz RF, Chamberland ME.

Emerg Infect Dis. 2004 Feb;10(2):185-94.

9.

Opportunities for control of meningococcal disease in the United States.

Raghunathan PL, Bernhardt SA, Rosenstein NE.

Annu Rev Med. 2004;55:333-53. Review.

PMID:
14746525
10.

Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.

Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, Mayer LW, Phelan M, Taylor TH Jr, Bernhardt SA, Rosenstein NE, Popovic T.

J Clin Microbiol. 2004 Jan;42(1):320-8.

11.

Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.

Tierney BC, Martin SW, Franzke LH, Marano N, Reissman DB, Louchart RD, Goff JA, Rosenstein NE, Sever JL, McNeil MM; Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program.

Clin Infect Dis. 2003 Oct 1;37(7):905-11. Epub 2003 Sep 12.

PMID:
13130401
12.

Neonatal meningococcal disease in the United States, 1990 to 1999.

Shepard CW, Rosenstein NE, Fischer M; Active Bacterial Core Surveillance Team.

Pediatr Infect Dis J. 2003 May;22(5):418-22.

PMID:
12792381
13.

Serogroup W-135 meningococcal disease during the Hajj, 2000.

Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, Badukhan A, Turkistani A, Makki S, Al-Hamdan N, Al-Jeffri M, Al Mazrou Y, Perkins BA, Popovic T, Mayer LW, Rosenstein NE.

Emerg Infect Dis. 2003 Jun;9(6):665-71. Erratum in: Emerg Infect Dis. 2003 Aug;9(8):1028.

14.

Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing.

LaClaire LL, Tondella ML, Beall DS, Noble CA, Raghunathan PL, Rosenstein NE, Popovic T; Active Bacterial Core Surveillance Team Members.

J Clin Microbiol. 2003 Jan;41(1):393-6.

15.

First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.

Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, Pillai SP, Popovic T, Quinn CP, Meyer RF, Zaki SR, Kumar S, Bruce SM, Sejvar JJ, Dull PM, Tierney BC, Jones JD, Perkins BA; Florida Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1029-34.

16.

Vaccines for the prevention of meningococcal disease in children.

Soriano-GabarrĂ³ M, Stuart JM, Rosenstein NE.

Semin Pediatr Infect Dis. 2002 Jul;13(3):182-9. Review.

PMID:
12199614
17.

Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis.

Scott RD 2nd, Meltzer MI, Erickson LJ, De Wals P, Rosenstein NE.

Am J Prev Med. 2002 Aug;23(2):98-105.

PMID:
12121797
18.

Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.

Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T, Rosenstein NE, Farley MM, Blake P, Stephens DS; Georgia Emerging Infections Program.

J Infect Dis. 2002 Jul 1;186(1):40-8. Epub 2002 Jun 7.

PMID:
12089660
19.

Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

Leake JA, Kone ML, Yada AA, Barry LF, Traore G, Ware A, Coulibaly T, Berthe A, Mambu Ma Disu H, Rosenstein NE, Plikaytis BD, Esteves K, Kawamata J, Wenger JD, Heymann DL, Perkins BA.

Bull World Health Organ. 2002;80(5):342-9.

20.

Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex.

Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, Schmink SE, Noble CA, Tondella ML, Whitney AM, Al-Mazrou Y, Al-Jefri M, Mishkhis A, Sabban S, Caugant DA, Lingappa J, Rosenstein NE, Popovic T.

J Infect Dis. 2002 Jun 1;185(11):1596-605. Epub 2002 May 17.

PMID:
12023765
21.

Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease.

Fry AM, Lurie P, Gidley M, Schmink S, Lingappa J, Fischer M, Rosenstein NE.

Pediatrics. 2001 Oct;108(4):E60.

PMID:
11581468
22.

Invasive meningococcal disease in adolescents and young adults.

Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, Bustamante A, Razeq J, Roche JC.

JAMA. 2001 Aug 8;286(6):694-9.

PMID:
11495619
23.

Risk factors for meningococcal disease in college students.

Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M.

JAMA. 2001 Aug 8;286(6):688-93.

PMID:
11495618
24.

Marijuana use and social networks in a community outbreak of meningococcal disease.

Krause G, Blackmore C, Wiersma S, Lesneski C, Woods CW, Rosenstein NE, Hopkins RS.

South Med J. 2001 May;94(5):482-5.

PMID:
11372796
25.

Meningococcal disease.

Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM.

N Engl J Med. 2001 May 3;344(18):1378-88. Review. No abstract available.

PMID:
11333996
26.

Meningococcal vaccines.

Rosenstein NE, Fischer M, Tappero JW.

Infect Dis Clin North Am. 2001 Mar;15(1):155-69. Review.

PMID:
11301813
27.

Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa.

Tondella ML, Rosenstein NE, Mayer LW, Tenover FC, Stocker SA, Reeves MW, Popovic T.

Emerg Infect Dis. 2001 Jan-Feb;7(1):163-4. No abstract available.

28.

Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996.

Rosenstein NE, Emery KW, Werner SB, Kao A, Johnson R, Rogers D, Vugia D, Reingold A, Talbot R, Plikaytis BD, Perkins BA, Hajjeh RA.

Clin Infect Dis. 2001 Mar 1;32(5):708-15. Epub 2001 Feb 28.

PMID:
11229838
29.

Global surveillance for meningococcal disease.

Rosenstein NE.

Methods Mol Med. 2001;67:333-9. doi: 10.1385/1-59259-149-3:333.

PMID:
21337154
30.

Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.

Sacchi CT, Whitney AM, Popovic T, Beall DS, Reeves MW, Plikaytis BD, Rosenstein NE, Perkins BA, Tondella ML, Mayer LW.

J Infect Dis. 2000 Oct;182(4):1169-76. Epub 2000 Sep 8.

PMID:
10979914
31.

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

Tondella ML, Popovic T, Rosenstein NE, Lake DB, Carlone GM, Mayer LW, Perkins BA.

J Clin Microbiol. 2000 Sep;38(9):3323-8.

32.

Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA, Ajello GW, Mostashari F, Bendana N, Lingappa J, Hajjeh R, Rosenstein NE.

Emerg Infect Dis. 2000 Jul-Aug;6(4):428-9. No abstract available.

33.

Update on Haemophilus influenzae serotype b and meningococcal vaccines.

Rosenstein NE, Perkins BA.

Pediatr Clin North Am. 2000 Apr;47(2):337-52, vi. Review.

PMID:
10761507
34.

Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention.

Woods CW, McRill C, Plikaytis BD, Rosenstein NE, Mosley D, Boyd D, England B, Perkins BA, Ampel NM, Hajjeh RA.

J Infect Dis. 2000 Apr;181(4):1428-34. Epub 2000 Apr 7.

PMID:
10753734
35.

Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team.

Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA.

Clin Infect Dis. 2000 Jan;30(1):212-3. No abstract available.

PMID:
10619761
36.

Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.

Woods CW, Armstrong G, Sackey SO, Tetteh C, Bugri S, Perkins BA, Rosenstein NE.

Lancet. 2000 Jan 1;355(9197):30-3.

PMID:
10615888
37.

The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL.

J Infect Dis. 1999 Dec;180(6):1894-901.

PMID:
10558946
38.

Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection.

Virata M, Rosenstein NE, Hadler JL, Barrett NL, Tondella ML, Mayer LW, Weyant RS, Hill B, Perkins BA.

Clin Infect Dis. 1998 Nov;27(5):1238-40.

PMID:
9827276
39.

Meningococcal vaccine in sub-Saharan Africa.

Perkins BA, Broome CV, Rosenstein NE, Schuchat A, Reingold AL.

Lancet. 1997 Dec 6;350(9092):1708; author reply 1709-10. No abstract available.

PMID:
9400540

Supplemental Content

Loading ...
Support Center